PetVivo Holdings, Inc. Conference Call Announcement
PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), a pioneering biomedical company known for its advanced therapeutic medical devices for both equines and companion animals, has announced a highly anticipated conference call. Scheduled for Monday, June 30, this call will begin at 5:00 p.m. ET and will focus on the company’s financial outcomes for the fiscal fourth quarter and year ending March 31.
Details of the Conference Call
The conference call will include a presentation led by the management team of PetVivo, providing insights into their performance and strategic direction. Following the presentation, there will be an interactive session where participants can ask questions.
For those wishing to participate, the conference call can be accessed via the dial-in number +1 253 205 0468. Participants will need the conference ID 83424004566 along with the passcode 352845 to join the discussion.
Additionally, the conference will be available as a live webcast, and participants can listen to the replay through a dedicated link that will go live post-call.
Innovative Approaches to Animal Health
PetVivo Holdings is at the forefront of developing medical solutions for companion animals. Their strategy is centered around creating and commercializing unique medical devices based on human therapies, which offers a quicker path to market compared to conventional pharmaceuticals. This approach aims to enhance the speed at which vital therapies can reach veterinary professionals and their patients.
The company boasts a strong pipeline of products designed to address various health issues faced by animals. They currently hold over twenty-one patents that protect their innovative biomaterials, production processes, and various applications, underscoring their commitment to animal health.
Highlighted Products
Among PetVivo's most significant offerings is SPRYNG™ with OsteoCushion™ technology. This veterinarian-administered injection is intended for managing joint-related conditions like lameness and osteoarthritis in pets such as dogs, cats, and horses. Additionally, their first-in-class PrecisePRP product brings a revolutionary option for veterinarians needing platelet-rich plasma solutions, streamlining the process with an off-the-shelf approach.
Contacting PetVivo Holdings
For further queries or detailed information regarding the conference call or the company’s health solutions, please reach out to:
John Lai, CEO
PetVivo Holdings, Inc.
Email: info1@petvivo.com
Phone: (952) 405-6216
Frequently Asked Questions
1. What is the purpose of the upcoming conference call?
The conference call aims to discuss PetVivo’s fiscal fourth quarter and annual results, along with strategic updates from management.
2. How can investors join the conference call?
Investors can join the call using the provided toll-free number and must enter the conference ID and passcode.
3. What products does PetVivo offer for animal health?
PetVivo offers innovative products, including SPRYNG™ with OsteoCushion™ technology and PrecisePRP, aimed at treating various health issues in animals.
4. Where can I find more information about PetVivo’s financial results?
Detailed financial results will be available in a press release prior to the conference call.
5. How does PetVivo ensure the safety and effectiveness of its products?
PetVivo's commitment includes rigorous patent protections for their biomaterials and innovative manufacturing processes, emphasizing quality and reliability.